Halliburton, Allergan, Celldex, Exterran and Amicus Therapeutics are big market movers

Energy Associated Press

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

Continue Reading Below

NYSE

Halliburton Co., down $5.85 to $49.23

The oilfield services company is buying rival Baker Hughes Inc. in a cash-and-stock deal worth $34.6 billion as oil prices tumble.

Allergan Inc., up $10.55 to $209.20

The Botox maker is being bought by Actavis for $66 billion, which tops a bid made by Valeant Pharmaceuticals last spring.

Continue Reading Below

Exterran Holdings Inc., up $3.04 to $36.81

The natural gas services company is spinning off its international and fabrication businesses into a new publicly traded company.

Denbury Resources Inc., down $1.19 to $10.01

The oil and gas producer plans to cut its 2015 capital spending by 50 percent because of the recent drop in oil prices.

Nasdaq

Celldex Therapeutics, up $4.09 to $18.25

An experimental drug developed by the biotechnology company helped extend survival rates of patients in a brain tumor study.

Amicus Therapeutics Inc., up $1.01 to $6.70

The biotechnology company reported positive results in a second late-stage study of its potential treatment for Fabry disease.

DreamWorks Animation SKG Inc., down $3.71 to $22.31

Talks between the animation studio and toy company Hasbro Inc. have faded, the Wall Street Journal reported late Friday.

ShoreTel Inc., down 80 cents to $7.41

Mitel Networks Corp. withdrew its buyout bid for the telecommunications services company, citing repeated refusals to talk.